Search Results

There are 28709 results for: content related to: Tumour burden is an independent prognostic factor in metastatic renal cell carcinoma

  1. You have free access to this content
    Tumour burden is an independent prognostic factor in metastatic renal cell carcinoma

    BJU International

    Volume 110, Issue 11, December 2012, Pages: 1747–1753, Roberto Iacovelli, Emilie Lanoy, Laurence Albiges and Bernard Escudier

    Version of Record online : 26 OCT 2012, DOI: 10.1111/j.1464-410X.2012.11518.x

  2. Immunotherapy for metastatic renal cell carcinoma

    Intervention Review

    The Cochrane Library

    Susanne Unverzagt, Ines Moldenhauer, Monika Nothacker, Dorothea Roßmeißl, Andreas V Hadjinicolaou, Frank Peinemann, Francesco Greco and Barbara Seliger

    Published Online : 15 MAY 2017, DOI: 10.1002/14651858.CD011673.pub2

  3. You have free access to this content
    Recent advances in the treatment of advanced renal cell carcinoma: towards multidisciplinary personalized care

    BJU International

    Volume 110, Issue 9, November 2012, Pages: 1289–1300, Axel Bex, Martin Gore, Peter Mulders and Cora N. Sternberg

    Version of Record online : 30 MAR 2012, DOI: 10.1111/j.1464-410X.2012.11100.x

  4. You have free access to this content
    Sunitinib-induced changes in circulating endothelial cell-related proteins in patients with metastatic renal cell cancer

    International Journal of Cancer

    Volume 131, Issue 4, 15 August 2012, Pages: E484–E493, Astrid A.M. van der Veldt, Laura Vroling, Richard R. de Haas, Pieter Koolwijk, Alfons J.M. van den Eertwegh, John B.A.G. Haanen, Victor W.M. van Hinsbergh, Henk J. Broxterman and Epie Boven

    Version of Record online : 8 NOV 2011, DOI: 10.1002/ijc.26456

  5. You have free access to this content
    The impact of tumor burden characteristics in patients with metastatic renal cell carcinoma treated with sunitinib

    Cancer

    Volume 117, Issue 6, 15 March 2011, Pages: 1183–1189, Naveen S. Basappa, Paul Elson, Ali-Reza Golshayan, Laura Wood, Jorge A. Garcia, Robert Dreicer and Brian I. Rini

    Version of Record online : 19 OCT 2010, DOI: 10.1002/cncr.25713

  6. You have free access to this content
    A new patient-focused approach to the treatment of metastatic renal cell carcinoma: establishing customized treatment options

    BJU International

    Volume 107, Issue 8, April 2011, Pages: 1190–1199, Joaquim Bellmunt, Tim Eisen, Cezary Szczylik, Peter Mulders and Camillo Porta

    Version of Record online : 15 NOV 2010, DOI: 10.1111/j.1464-410X.2010.09829.x

  7. You have free access to this content
    Abstracts

    BJU International

    Volume 116, Issue S5, December 2015, Pages: 1–23,

    Version of Record online : 9 DEC 2015, DOI: 10.1111/bju.13365

  8. You have free access to this content
    Association of percentage of tumour burden removed with debulking nephrectomy and progression-free survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy

    BJU International

    Volume 106, Issue 9, November 2010, Pages: 1266–1269, Juan Barbastefano, Jorge A. Garcia, Paul Elson, Laura S. Wood, Brian R. Lane, Robert Dreicer, Steven C. Campbell and Brian I. Rini

    Version of Record online : 23 MAR 2010, DOI: 10.1111/j.1464-410X.2010.09323.x

  9. You have free access to this content
    Current management and future perspectives of metastatic renal cell carcinoma

    International Journal of Urology

    Volume 21, Issue 9, September 2014, Pages: 847–855, Richard Lee-Ying, Renee Lester and Daniel YC Heng

    Version of Record online : 27 MAY 2014, DOI: 10.1111/iju.12502

  10. You have free access to this content
    Clinical and immunomodulatory effects of bevacizumab and low-dose interleukin-2 in patients with metastatic renal cell carcinoma: results from a phase II trial

    BJU International

    Volume 107, Issue 4, February 2011, Pages: 562–570, Jorge A. Garcia, Tarek Mekhail, Paul Elson, Pierre Triozzi, Cheryl Nemec, Robert Dreicer, Ronald M. Bukowski and Brian I Rini

    Version of Record online : 14 SEP 2010, DOI: 10.1111/j.1464-410X.2010.09573.x

  11. You have free access to this content
    Current status of pharmacotherapy against metastatic renal cell carcinoma in Japan

    International Journal of Urology

    Volume 19, Issue 4, April 2012, Pages: 284–295, Yoshihiro Wada, Wataru Takahashi, Yoshiaki Kawano and Masatoshi Eto

    Version of Record online : 27 MAR 2012, DOI: 10.1111/j.1442-2042.2012.02962.x

  12. You have free access to this content
    Optimal management of metastatic renal cell carcinoma: an algorithm for treatment

    BJU International

    Volume 104, Issue 1, July 2009, Pages: 10–18, Joaquim Bellmunt, Per Flodgren, Jan Roigas and Stéphane Oudard

    Version of Record online : 21 APR 2009, DOI: 10.1111/j.1464-410X.2009.08563.x

  13. You have free access to this content
    Prognostic impact of baseline serum C-reactive protein in patients with metastatic renal cell carcinoma (RCC) treated with sunitinib

    BJU International

    Volume 114, Issue 1, July 2014, Pages: 81–89, Benoit Beuselinck, Yann-Alexandre Vano, Stéphane Oudard, Pascal Wolter, Robert De Smet, Lore Depoorter, Corine Teghom, Alexandra Karadimou, Jessica Zucman-Rossi, Philip R. Debruyne, Hendrik Van Poppel, Steven Joniau, Evelyne Lerut, Michiel Strijbos, Herlinde Dumez, Robert Paridaens, Ben Van Calster and Patrick Schöffski

    Version of Record online : 15 JAN 2014, DOI: 10.1111/bju.12494

  14. You have free access to this content
    Abstracts

    BJU International

    Volume 114, Issue S4, October 2014, Pages: 1–18,

    Version of Record online : 21 OCT 2014, DOI: 10.1111/bju.12941

  15. You have free access to this content
    Use of tyrosine kinase inhibitors in patients with metastatic kidney cancer receiving haemodialysis: a retrospective Italian survey

    BJU International

    Volume 110, Issue 5, September 2012, Pages: 692–698, Cristina Masini, Roberto Sabbatini, Camillo Porta, Giuseppe Procopio, Giuseppe Di Lorenzo, Azzurra Onofri, Sebastiano Buti, Roberto Iacovelli, Roberta Invernizzi, Luca Moscetti, Maria Giuseppina Aste, Maria Pagano, Federica Grosso, Anna Lucia Manenti, Cinzia Ortega, Laura Cosmai, Cinzia Del Giovane and Pier Franco Conte

    Version of Record online : 24 FEB 2012, DOI: 10.1111/j.1464-410X.2012.10946.x

  16. You have free access to this content
    Abstracts

    BJU International

    Volume 118, Issue S5, December 2016, Pages: 4–30,

    Version of Record online : 17 NOV 2016, DOI: 10.1111/bju.13694

  17. You have free access to this content
    Overall survival in patients with metastatic renal cell carcinoma initially treated with bevacizumab plus interferon-α2a and subsequent therapy with tyrosine kinase inhibitors: a retrospective analysis of the phase III AVOREN trial

    BJU International

    Volume 107, Issue 2, January 2011, Pages: 214–219, Sergio Bracarda, Joaquim Bellmunt, Bohuslav Melichar, Sylvie Négrier, Emilio Bajetta, Alain Ravaud, Vesna Sneller and Bernard Escudier

    Version of Record online : 13 OCT 2010, DOI: 10.1111/j.1464-410X.2010.09707.x

  18. You have free access to this content
    Phase II trial of continuous once-daily dosing of sunitinib as first-line treatment in patients with metastatic renal cell carcinoma

    Cancer

    Volume 118, Issue 5, 1 March 2012, Pages: 1252–1259, Carlos H. Barrios, David Hernandez-Barajas, Michael P. Brown, Se-Hoon Lee, Luis Fein, Jin-Hwang Liu, Subramanian Hariharan, Bridget A. Martell, Jinyu Yuan, Akintunde Bello, Zhixiao Wang, Rajiv Mundayat and Sun-Young Rha

    Version of Record online : 6 SEP 2011, DOI: 10.1002/cncr.26440

  19. You have free access to this content
    Feasibility and efficacy of neoadjuvant sunitinib before nephron-sparing surgery

    BJU International

    Volume 106, Issue 9, November 2010, Pages: 1270–1276, Jonathan L. Silberstein, Frederick Millard, Reza Mehrazin, Ryan Kopp, Wassim Bazzi, Christopher J. DiBlasio, Anthony L. Patterson, Tracy M. Downs, Furhan Yunus, Christopher J. Kane and Ithaar H. Derweesh

    Version of Record online : 15 APR 2010, DOI: 10.1111/j.1464-410X.2010.09357.x

  20. You have free access to this content
    Management of sunitinib adverse events in renal cell carcinoma patients: The Asian experience

    Asia-Pacific Journal of Clinical Oncology

    Volume 8, Issue 2, June 2012, Pages: 132–144, Aiping ZHOU

    Version of Record online : 24 APR 2012, DOI: 10.1111/j.1743-7563.2012.01525.x